All-trans-retinoic acid induces tyrosine phosphorylation of the CrkL adapter in acute promyelocytic leukemia cells

Experimental Hematology

Volumn 28, Issue 7, 2000, Pages 826-832

  Alsayed, Yazan ^a   Modi, Sanjiv ^a   Uddin, Shahab ^a   Mahmud, Nadim ^a   Druker, Brian J ^b   Fish, Eleanor N ^c   Hoffman, Ronald ^a   Platanias, Leonidas C ^a  

^a UNIVERSITY OF ILLINOIS AT CHICAGO   (United States)

^b OREGON HEALTH AND SCIENCE UNIVERSITY   (United States)

^c UNIVERSITY OF TORONTO   (Canada)

Author keywords

Leukemia; Retinoic acid; Tyrosine kinases

Indexed keywords

CELL PROTEIN; GLUTATHIONE TRANSFERASE; GUANINE NUCLEOTIDE BINDING PROTEIN; HYBRID PROTEIN; PROTEIN TYROSINE KINASE; RETINOIC ACID;

ARTICLE; CELL DIFFERENTIATION; CELL STRAIN HL 60; CONTROLLED STUDY; ENZYME PHOSPHORYLATION; FLOW CYTOMETRY; HUMAN; HUMAN CELL; IMMUNOPRECIPITATION; PRIORITY JOURNAL; PROMYELOCYTIC LEUKEMIA; PROTEIN DOMAIN; PROTEIN INTERACTION; SIGNAL TRANSDUCTION; WESTERN BLOTTING;

ADAPTOR PROTEINS, SIGNAL TRANSDUCING; ANTINEOPLASTIC AGENTS; ELECTROPHORESIS, POLYACRYLAMIDE GEL; HL-60 CELLS; HUMANS; LEUKEMIA, PROMYELOCYTIC, ACUTE; MOLECULAR WEIGHT; NUCLEAR PROTEINS; PHOSPHORYLATION; PROTO-ONCOGENE PROTEINS; PROTO-ONCOGENE PROTEINS C-CBL; RAP1 GTP-BINDING PROTEINS; SRC HOMOLOGY DOMAINS; TRETINOIN; TUMOR CELLS, CULTURED; TYROSINE; UBIQUITIN-PROTEIN LIGASES;

EID: 0034089137     PISSN: 0301472X     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0301-472X(00)00170-3     Document Type: Article

References (51)

1. Tallman S. All-trans-retinoic acid in acute promyelocytic leukemia and its potential in other hematologic malignancies. Semin Hematol. 31:1994;38.
2. Fenaux P., Degos L. Treatment of acute promyelocytic leukemia. Bailieres Clin Haematol. 9:1996;107.
3. Tallman S. Differentiation therapy in acute myeloid leukemia. Leukemia. 10:1996;1262.
4. Grignani F., Fagioli M., Alcalay M.et al. Acute promyelocytic leukemia. from genetics to treatment Blood. 83:1994;10.
5. Chambon P. The retinoid signaling pathway. molecular and genetic analyses Semin Cell Biol. 5:1994;115.
6. Mangelsdorf D.J., Evans R.M. The RXR heterodimers and orphan receptor. Cell. 83:1995;841.
7. Collins S.J., Robertson K., Mueller L. Retinoic acid induced granulocytic differentiation of HL-60 myeloid leukemia cells is mediated directly through the retinoic acid receptor (RARα). Mol Cell Biol. 10:1990;2154.
8. Tsai S., Bartelmez S., Heyman R.et al. A mutated retinoic acid receptor exhibiting dominant-negative activity alters the lineage development of a multipotent hematopoietic cell line. Genes Dev. 6:1992;2258.
9. Froeschle A., Carnac G., Alric S.et al. RXR alpha is essential for mediating the all-trans-retinoic acid-induced growth arrest of C2 myogenic cells. Oncogene. 12:1996;411.
10. Wang Z.G., Delva L., Gaboli M.et al. Role of the PML gene and the retinoic acid pathway. Science. 279:1998;1547.
11. Katagiri K., Yokoyama K.K., Yamamoto T.et al. Lyn and Fgr protein-tyrosine kinases prevent apoptosis during retinoic acid-induced granulocytic differentiation of HL-60 cells. J Biol Chem. 271:1996;11557.
12. Gaboli M., Gandini D., Delva L.et al. Acute promyelocytic leukemia as a model for cross talk between interferon and retinoic acid pathways. from molecular biology to clinical application Leuk Lymphoma. 30:1998;11.
13. Yetter A., Uddin S., Krolewski J.J.et al. Association of the interferon-dependent tyrosine kinase Tyk-2 with the hematopoietic cell phosphatase. J Biol Chem. 270:1995;18179.
14. Uddin S., Fish E.N., Sher D.et al. The IRS-pathway operates distinctively from the Stat-pathway in hematopoietic cells and transduces common and distinct signals during engagement of the insulin or interferon α receptors. Blood. 90:1997;2574.
15. Uddin S., Mazchrzak B., Woodson J.et al. Activation of the p38 map kinase by Type I interferons. J Biol Chem. 274:1999;30127.
16. Heaney C., Kolibaba K., Bhat A.et al. Direct binding of CRKL to BCR-ABL is not required for BCR-ABL transformation. Blood. 89:1997;297.
17. Uddin S., Yenush L., Sun X.-J.et al. Interferon α engages the insulin receptor substrate-1 to associate with the phosphatidylinositol 3′-kinase. J Biol Chem. 270:1995;15938.
18. +-mediated activation of Rap1 in human platelets. EMBO J. 16:1997;252.
19. Reedquist K.A., Bos J.L. Costimulation through CD28 suppresses T cell receptor-dependent activation of the Ras-like small GTPase Rap1 in human T lymphocytes. J Biol Chem. 273:1998;4494.
20. M'Rabet L., Coffer P., Zwartkruis F.et al. Activation of the small GTPase rap1 in human neutrophils. Blood. 92:1998;2133.
21. Wickrema A., Uddin S., Sharma A.et al. Engagement of Gab1 and Gab2 in erythropoietin signalling. J Biol Chem. 274:1999;24469.
22. Gupta A.K., Kolibaba K., Zibello T.A.et al. NB4 cells show bilineage potential and aberrant pattern of neutrophil secondary granule protein gene expression. Blood. 84:1994;294.
23. Lanotte M., Martin-Thoruvenin V., Najman S.et al. NB4, a maturation inducible cell line with t(15;17) marker isolated from a human acute promyelocytic leukemia (M3). Blood. 77:1991;1080.
24. Kolla V., Lindner D.J., Weihua X.et al. Modulation of interferon (IFN)-inducible gene expression by retinoic acid. Up-regulation of Stat1 protein in IFN-unresponsive cells. J Biol Chem. 271:1996;10508.
25. Weihua X., Kolla V., Kalvakolanu D.V. Modulation of interferon action by retinoids. Induction of murine Stat1 gene expression by retinoic acid. J Biol Chem. 272:1997;9742.
26. Gianni M., Terao M., Fortino I.et al. Stat1 is induced and activated by all-trans retinoic acid in acute promyelocytic leukemia cells. Blood. 89:1997;1001.
27. Matikainen S., Ronni T., Hurme M.et al. Retinoic acid activates interferon regulatory factor gene expression in myeloid cells. Blood. 88:1996;114.
28. Matikainen S., Ronni T., Lehtonen A.et al. Retinoic acid induces signal transducer and activator of transcription STAT1, STAT2, and p48 expression in myeloid leukemia cells and enhances their responsiveness to interferons. Cell Growth Differ. 8:1997;687.
29. Uddin S., Gardziola C., Dangat A.et al. Interaction of the c-cbl proto-oncogene product with the Tyk-2 protein tyrosine kinase. Biochem Biophys Res Commun. 225:1996;833.
30. Alsayed Y., Uddin S., Ahmad S.et al. Interferon γ activates the C3G-Rap1 signaling pathway. J Immunol. 164:2000;1800.
31. Ahmad S., Alsayed Y., Druker B.J.et al. The type I interferon receptor mediates tyrosine phosphorylation of the CrkL adaptor protein. J Biol Chem. 272:1997;29991.
32. Platanias L.C., Uddin S., Bruno E.et al. CrkL and CrkII participate in the generation of the growth inhibitory effects of interferons on primary hematopoietic progenitors. Exp Hematol. 27:1999;1315.
33. Fish E.N., Uddin S., Korkmaz M.et al. Activation of a CrkL-Stat5 signaling complex by Type I interferons. J Biol Chem. 274:1999;571.
34. Chelbi-Alix M.K., Pelicano L. Retinoic acid and interferon signaling cross talk in normal and RA-resistant APL cells. Leukemia. 13:1999;1167.
35. Giandomenico V., Lancilotti F., Fiorucci G.et al. Retinoic acid and IFN inhibition of cell proliferation is associated with apoptosis in squamous carcinoma cell lines. role of IRF-1 and Tgase II-dependent pathways Cell Growth Differ. 8:1997;91.
36. Kumar R., Korutla L. Growth inhibition of human acute promyelocytic leukemia NB-4 cells by interferons and all-trans-retinoic acid. trans-modulation of inducible gene expression pathways Anticancer Res. 15:1995;353.
37. Lancilotti F., Giandomenico V., Affabris E.et al. Interferon alpha-2b and retinoic acid combined treatment affects proliferation and gene expression of human cervical carcinoma cells. Cancer Res. 55:1995;3158.
38. Pelicano L., Li F., Schindler C.et al. Retinoic acid enhances the expression of interferon-induced proteins. evidence for multiple mechanisms of action Oncogene. 15:1998;2349.
39. Platanias L.C., Fish E.N. Signaling pathways activated by interferons. Exp Hematol. 27:1999;1583.
40. Meisner H., Czech M.P. Coupling of the proto-oncogene product c-Cbl to the epidermal growth factor receptor. J Biol Chem. 270:1995;25332.
41. cbl is a cytosolic adapter protein that associates with phosphoinositide 3-kinase in response to epidermal growth factor in PC12 and other cells. J Biol Chem. 271:1996;563.
42. Tanaka S., Neff L., Baron R.et al. Tyrosine phosphorylation and translocation of the c-Cbl protein after activation of tyrosine kinase signaling pathways. J Biol Chem. 270:1995;14347.
43. Marcilla A., Rivero-Lezcano O.M., Agarwal A.et al. Identification of the major tyrosine kinase substrate in signaling complexes formed after engagement of Fcγ receptors. J Biol Chem. 270:1995;9115.
44. Donovan J.A., Wange R.L., Langdon W.Y.et al. The protein product of the c-cblproto-oncogene is the 120 kDa tyrosine phosphorylated protein in Jurkat cells activated via the T cell antigen receptor. J Biol Chem. 269:1994;22921.
45. Meisner H., Conway B.R., Hartley D.et al. Interactions of Cbl with Grb-2 and phosphatidylinositol 3′-kinase in activated Jurkat cells. J Biol Chem. 15:1995;3571.
46. Odai H., Sasaki K., Iwamatsu A.et al. The proto-oncogene product c-Cbl becomes tyrosine phosphorylated by stimulation with GM-CSF or Epo and constitutively binds to the SH3 domain of Grb2/Ash in human hematopoietic cells. J Biol Chem. 270:1995;10800.
47. Rivero-Lezcano O.M., Sameshima J.H., Marcilla A.et al. Physical association between Src homology 3 elements and the protein product of the c-cbl proto-oncogene. J Biol Chem. 269:1994;17363.
48. cbl is a major substrate of tyrosine phosphorylation upon B cell antigen receptor stimulation and interacts in vivo with Fyn and Syk tyrosine kinases, Grb2 and Shc adaptors, and the p85 subunit of phosphatidylinositol 3-kinase. J Biol Chem. 271:1996;3187.
49. Kitayama H., Matsuzaki T., Ikawa Y.et al. Genetic analysis of the Kirsten- ras-revertant 1 gene. potentiation of its tumor suppressor activity by specific point mutations Proc Natl Acad Sci U S A. 87:1990;4284.
50. Cook S., Rubinfeld B., Albert I.et al. RapV12 antagonizes Ras-dependent activation of ERK1 and ERK2 by LPA and EGF in Rat-1 fibroblasts. EMBO J. 12:1993;3475.
51. Uddin S., Grumbach I., Yi T.et al. Interferon α activates the tyrosine kinase Lyn in hematopoietic cells. Br J Haematol. 101:1998;446.